0001415889-24-016071.txt : 20240607
0001415889-24-016071.hdr.sgml : 20240607
20240607182536
ACCESSION NUMBER: 0001415889-24-016071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREY MICHAEL G
CENTRAL INDEX KEY: 0001240122
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38981
FILM NUMBER: 241031037
MAIL ADDRESS:
STREET 1: C/O SGX PHARMACEUTICALS, INC.
STREET 2: 10505 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001759425
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831281555
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-667-4085
MAIL ADDRESS:
STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
form4-06072024_100632.xml
X0508
4
2024-06-05
0001759425
Mirum Pharmaceuticals, Inc.
MIRM
0001240122
GREY MICHAEL G
C/O MIRUM PHARMACEUTICALS, INC.
989 E HILLSDALE BLVD., SUITE 300
FOSTER CITY
CA
94404
true
false
false
false
0
Stock Option (right to buy)
26.30
2024-06-05
4
A
0
8779
0
A
2034-06-04
Common Stock
8779
8779
D
Deferred Stock Units
2024-06-05
4
A
0
5703
0
A
Common Stock
5703
5703
D
The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting.
Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer.
/s/ Judit Ryvkin, Attorney-in-Fact
2024-06-07